Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Spinal Surgery Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 10-06-2019
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
Discectomy
Facetectomy
Foraminotomy
Laminotomy
Spinal Fusion
Instrumented And Non-Instrumented Spinal Fusion
Cervical Fusion
Interbody Fusion
Lumbar Fusion
Fracture Repair Devices
Arthroplasty Devices
Non-fusion Devices
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
iscectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
iscectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Stem Cell Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 13-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 13-06-2019
Market Overview
The stem cell market is experiencing growth, owing to the increasing number of clinical trials around the world. North America, especially the United States, dominated the number of trials undergoing in stem cell therapies. The United States dominates the market in both the products and banking services segments, holding around 77.4% of the total North American market. However, Asia-Pacific is growing at the highest growth rate. Stem cells are majorly used in regenerative medicine, especially in the field of dermatology. However, oncology is expected to grow at the highest growth rate, due to a large number of pipeline products present for the treatment of tumors or cancers. With the increase in the number of regenerative medicine centers, the stem cell market is also expected to increase in the future.
Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.
Scope of the Report
The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.
Key Market Trends
Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.
Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.
Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.
North America Captured The Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.
Competitive Landscape
The stem cell market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies, is in turn, increasing the overall competitive rivalry in the market. The product advancements and improvement in stem cell technology by the major players are increasing the competitive rivalry.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Awareness about Umbilical Stem Cell
4.2.2 Increase in the Approval for Clinical Trials in Stem Cell Research
4.2.3 Growing Demand for Regenerative Treatment Option
4.2.4 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases
4.3 Market Restraints
4.3.1 Expensive Procedures
4.3.2 Regulatory Complications
4.3.3 Ethical and Moral Framework
4.4 Industry Attractiveness- Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Adult Stem Cell
5.1.2 Human Embryonic Cell
5.1.3 Pluripotent Stem Cell
5.1.4 Other Product Types
5.2 By Therapeutic Application
5.2.1 Neurological Disorders
5.2.2 Orthopedic Treatments
5.2.3 Oncology Disorders
5.2.4 Diabetes
5.2.5 Injuries and Wounds
5.2.6 Cardiovascular Disorders
5.2.7 Other Therapeutic Applications
5.3 By Treatment Type
5.3.1 Allogeneic Stem Cell Therapy
5.3.2 Auto logic Stem Cell Therapy
5.3.3 Syngeneic Stem Cell Therapy
5.4 By Banking Service and Technology
5.4.1 Stem Cell Acquisition and Testing
5.4.2 Cell Production
5.4.3 Expansion
5.4.4 Sub-culture
5.4.5 Cryopreservation
5.5 By Type of Banking
5.5.1 Public
5.5.2 Private
5.6 Geography
5.6.1 North America
5.6.1.1 US
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 UK
5.6.2.2 Germany
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East & Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East & Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Osiris Therapeutics Inc.
6.1.2 Pluristem Therapeutics Inc.
6.1.3 Thermo Fisher Scientific
6.1.4 Qiagen NV
6.1.5 Sigma Aldrich Corporation
6.1.6 Becton, Dickinson and Company
6.1.7 Stem Cell Technologies Inc.
6.1.8 AllCells LLC
6.1.9 Miltenyi Biotec
6.1.10 International Stem Cell Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
Adult Stem Cell
Human Embryonic Cell
Pluripotent Stem Cell
Other Product Types
By Therapeutic Application
Neurological Disorders
Orthopedic Treatments
Oncology Disorders
Diabetes
Injuries and Wounds
Cardiovascular Disorders
Other Therapeutic Applications
By Treatment Type
Allogeneic Stem Cell Therapy
Auto logic Stem Cell Therapy
Syngeneic Stem Cell Therapy
By Banking Service and Technology
Stem Cell Acquisition and Testing
Cell Production
Expansion
Sub-culture
Cryopreservation
By Type of Banking
Public
Private
Geography
North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Surgical Site Infection Control Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
Currently, the global SSI control market is in the growing phase and is dominated by hospitals and developed regions, like North America. Increasing hospital-acquired infections and number of surgeries are increasingly driving the SSI control market across the world. Increased focus on preventing SSI through appropriate measures has further augmented the market in developed regions. Awareness about surgical site infections is also higher in the developed regions. This has led to higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted this market positively.
Scope of the Report
As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery, in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ related.
Key Market Trends
Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There is an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs are considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.
Competitive Landscape
3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Grou,p and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Hospital Acquired Infection
4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control
4.2.3 Increasing Number of Surgeries
4.2.4 Rapidly Growing Geriatric Population
4.3 Market Restraints
4.3.1 Lack of Awareness of Hospital Infection Prevention and Control
4.3.2 Increased Use of Outpatient Treatment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Manual Reprocessors Solution
5.1.2 Disinfectants
5.1.2.1 Hand Disinfectants
5.1.2.2 Skin Disinfectants
5.1.3 Surgical Scrubs
5.1.4 Hair Clippers
5.1.5 Surgical Drapes
5.1.6 Surgical Irrigation
5.1.7 Skin Preparation Solution
5.1.8 Medical Nonwovens
5.1.9 Surgical Gloves
5.1.10 Other Products
5.2 By Surgery/Procedure
5.2.1 Cataract Surgery
5.2.2 Cesarean Section
5.2.3 Dental Restoration
5.2.4 Gastric Bypass
5.2.5 Other Surgeries/Procedures
5.3 By Type of Infection
5.3.1 Superficial Incisional SSI
5.3.2 Deep Incisional SSI
5.3.3 Organ or Space SSI
5.4 By End User
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centers
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Becton, Dickinson and Company
6.1.3 Belimed AG
6.1.4 bioMerieux SA
6.1.5 Getinge Group
6.1.6 Johnson & Johnson
6.1.7 Kimberly-Clark Corporation
6.1.8 Sotera Health
6.1.9 Ansell Limited
6.1.10 Steris Corporation
6.1.11 Lac-Mac Limited
6.1.12 Pacon Manufacturing Corp.
6.1.13 American Polyfilm Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Manual Reprocessors Solution
Disinfectants
Hand Disinfectants
Skin Disinfectants
Surgical Scrubs
Hair Clippers
Surgical Drapes
Surgical Irrigation
Skin Preparation Solution
Medical Nonwovens
Surgical Gloves
Other Products
By Surgery/Procedure
Cataract Surgery
Cesarean Section
Dental Restoration
Gastric Bypass
Other Surgeries/Procedures
By Type of Infection
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
By End User
Hospitals
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Tele Intensive Care Unit Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 13-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 13-06-2019
Market Overview
The tele-intensive care unit market was valued at USD 2,441.38 million in 2018, and it is estimated to be valued at USD 6,715.61 million by 2024, while witnessing a CAGR of 18.37% during the forecast period of 2019-2024. Factors that are responsible for the growth of the market include, rising geriatric population across the world and increasing demand for remote patient monitoring in developing regions.
With the increasing geriatric population and prevalence of chronic diseases, there is a growing need to find new ways of improving patient outcomes, increasing access to care, and reducing the cost of medical care. Using remote patient monitoring, which utilizes devices to remotely collect and direct information to a remote diagnostic testing facility for interpretation, the healthcare providers, insurance payers, and the various governments are seeking to alter the way in which care is being delivered, thus reducing the cost of care at the same time. As the aging population creates an increase in health-related issues, especially cardiovascular and neurological diseases, the hospitalization of the patients is also expected to rise. This hospitalization is likely to lead to some sort of surgeries that require intensive care, and this is expected to drive the tele-intensive care unit market.
Scope of the Report
The tele-intensive care unit (ICU) is like the second set of eyes that provides additional clinical support and surveillance. Collaborating tele ICU with the bedside team can provide support care for the patient without any distraction, and can deliver in timely interventions when minutes may make a huge difference. The major purpose of the tele ICU system is not to replace the bedside clinicians or bedside care, but to provide improved safety through redundancy and enhance outcomes through standardization.
Key Market Trends
Therapeutic Devices Sub-segment is Expected to Hold the Largest Market Share in the Hardware Segment
In the hardware segment of the tele-intensive care unit market, the therapeutic devices sub-segment is expected to have largest market share, and is expected to witness a CAGR of 18.51% over the forecast period.
In the past decade, there were several studies being conducted by engineers and clinicians to apply robotic devices in multiple indications of heart and brain, such as stroke therapy. The therapeutic devices are highly useful in the decentralized tele ICU. A large number of nursing activities are increasing their dependency and providing better patient management through therapeutic devices, even when they are disengaged from therapeutic interactions.
The therapeutics devices have achieved success in transferring the neurological/cancer examinations, diagnosis, and consultations across a range of distances in several developed countries. Therapeutic devices under tele ICU are aiding its importance, with the potential to help providers and caregivers to improve the post-acute care, specifically for patients leaving the ICUs. Thus, over the forecast period, the awareness about these devices is expected to significantly improve across the emerging markets.
North America Dominates the Market and is Expected to do Same during the Forecast Period
North America currently dominates the tele-intensive care unit market and is expected to continue its stronghold for a few more years. The emergence of novel technologies, along with their adoption, is helping the United States to grow in the healthcare sector. Rising healthcare expenditure is the prime factor responsible for the growth of this sector. The rapid increase in the older population and rising life expectancy are propelling the growth of the tele ICU market in the country. Due to the rising older population, an increasing number of emergency cases are coming to ICU departments in hospitals, which in turn, is creating the need for improved ICU care. Therefore, the market for tele ICUs is expected to experience growth in the North American region over the forecast period.
Competitive Landscape
The tele-intensive care unit market is highly competitive and consists of several major players. In terms of market share, there is moderate consolidation in the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with less prices. Companies, like Banner Health, INTeLeICU, Philips (VISICU), InTouch Technologies Inc., and Inova, hold the substantial market share in the tele-intensive care unit market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population
4.2.2 Increasing Demand for Remote Patient Monitoring
4.3 Market Restraints
4.3.1 High Cost of Treatment and Expensive Set Up
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Component
5.1.1 Hardware
5.1.1.1 Therapeutic Devices
5.1.1.2 Communication Lines
5.1.1.3 Computer Systems
5.1.1.4 Physiological Monitors
5.1.1.5 Display Panels
5.1.1.6 Video Feed
5.1.1.7 Other Hardware
5.1.2 Software and Services
5.2 By Type of Management
5.2.1 Intensivist
5.2.2 Open
5.2.3 Co-managed
5.2.4 Open with Consultant
5.2.5 Other Types of Management
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Advanced ICU Care
6.1.2 Banner Health
6.1.3 iMDsoft
6.1.4 INTeLeICU
6.1.5 InTouch Technologies Inc.
6.1.6 Koninklijke Philips NV
6.1.7 SOC Telemed
6.1.8 UPMC Italy
6.1.9 Apollo Telehealth Services
6.1.10 Advanced ICU Care
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Component
Hardware
Therapeutic Devices
Communication Lines
Computer Systems
Physiological Monitors
Display Panels
Video Feed
Other Hardware
Software and Services
By Type of Management
Intensivist
Open
Co-managed
Open with Consultant
Other Types of Management
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Telemedicine Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 114 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 114 pages
- Published: 07-06-2019
Market Overview
The global telemedicine market was valued at USD 38,046 million in 2018, and it is estimated to be valued at USD 103,897.77 million in 2024, witnessing a CAGR of 18.23%. Certain factors that are driving the market growth include increasing medicare reimbursement for telehealth services, increasing prevalence of chronic diseases, and technological innovation in communication technology across the world
Medicine these days is increasingly dependent on technology. The use of technology to transfer large amounts of digital information effortlessly at a relatively low cost is possible through telemedicine. With telemedicine, healthcare experts can listen to a patient’s heart remotely, look at and operate an electrocardiogram (ECG), X-rays, computed tomography (CT) scans, and other imaging data, obtained from several hundred miles away.
Many innovative strategies have provided consumers with insights into their own health. Recent advancements in the use of sensor technology and data capture have created opportunities for patients to conduct their own home-health check. The equipment to support telemedicine can be accessed using everyday technology, such as tablets, mobiles, and laptops. Hence, these technological innovations are driving the telemedicine market.
Scope of the Report
As per the scope of the report, telemedicine services and systems have made the most progress in remote management of post-acute care patients with chronic conditions. Telemedicine is the remote delivery of healthcare services, such as consultations over the telecommunication or teleconference, which allows healthcare professionals to evaluate, diagnose, and treat patients.
Key Market Trends
On-premise Delivery is Expected to Dominate the Telemedicine Market
The on-premise delivery segment of the telemedicine market is believed to have largest market size and is expected to witness a CAGR of 16.7% during the forecast period.
Along with that, telecardiology, a sub-segment of clinical service, is expected to have the largest market size during the forecast period and is expected to register a CAGR of 18.4%. Telecardiology is gradually started to increase in emerging markets. It provides all kinds of cardiac investigations, like basic lipid profile (cholesterol levels), electrocardiogram (ECG), echocardiogram (ECHO), coronary angiogram, Holter monitor (24 Hours ambulatory ECG monitoring), stress echo, pediatric echo, treadmill testing (TMT), carotid ultrasounds, etc.
Apart from reaching to patients directly, telecardiology services are useful in improving the efficiency in cardiac units of hospitals and medical imaging practices. With the number of cardiac patients increasing every day, remote monitoring helps in cost saving, up to around 50%, including improved patient satisfaction and quality of life, when compared to traditional outpatient care.
North America is Expected to Dominate the Market
North America currently dominates the market for telemedicine and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of telemedicine and rising demand for mobile health services. The United States holds the majority of the market in the North American region, due to the involvement of accountable care organizations (ACOs) in both medicare and privately insured services. In addition, there is a rise in per capita health expenditure in the country, which is expected to increase over the forecast period, owing to decrease in the unemployment rate.
Competitive Landscape
The telemedicine market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products with fewer prices. Companies, like Allscripts Healthcare Solutions Inc., BioTelemetry, Medtronic, and Philips, hold significant market shares in the telemedicine market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Growing Medicare Reimbursement for Telehealth Services
4.2.3 Technological Innovation in Communication Technology
4.3 Market Restraints
4.3.1 Privacy and Security Concerns in Telehealth
4.3.2 Lack of Interoperability Between eHealth Solutions
4.3.3 Inadequate or Fragmented Legal Frameworks Including the Lack of Reimbursement Schemes for eHealth Services
4.4 Industry Attractiveness of Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Telehospitals
5.1.2 Telehomes
5.1.3 mHealth (Mobile Health)
5.2 By Clinical Service
5.2.1 Teleconsultation
5.2.2 Telepathology
5.2.3 Telecardiology
5.2.4 Telesurgery
5.2.5 Teleradiology
5.2.6 Teledermatology
5.2.7 Telepsychiatry
5.2.8 Other Clinical Services
5.3 By Technology
5.3.1 Hardware
5.3.2 Software
5.3.3 Telecom
5.4 By Mode of Delivery
5.4.1 On-premise Delivery
5.4.2 Cloud-based Delivery
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 United Kingdom
5.5.2.2 Germany
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aerotel Medical Systems
6.1.2 AMD Global Telemedicine Inc.
6.1.3 BioTelemetry
6.1.4 Honeywell Life Care Solutions
6.1.5 InTouch Technologies Inc.
6.1.6 Medtronic
6.1.7 Philips
6.1.8 SHL Telemedicine Ltd
6.1.9 Allscripts Healthcare Solutions Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Telehospitals
Telehomes
mHealth (Mobile Health)
By Clinical Service
Teleconsultation
Telepathology
Telecardiology
Telesurgery
Teleradiology
Teledermatology
Telepsychiatry
Other Clinical Services
By Technology
Hardware
Software
Telecom
By Mode of Delivery
On-premise Delivery
Cloud-based Delivery
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Transradial Access Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 07-06-2019
Market Overview
The Transradial Access Devices Market is growing because of increasing preference for interventional procedures using radial artery access, the growing prevalence of cardiovascular diseases and increasing use of radial access devices in pediatric patients.
There are various applications of transradial access procedure. It is used in the diagnosis of coronary artery diseases including diagnostic angiography, angioplasty, and percutaneous stenting. When a person suffers from chest pain, this procedure can determine the blockage in heart arteries. Furthermore, it also helps healthcare providers to determine a treatment plan. This test is called coronary angiography. If a patient has a known blockage in a coronary artery, cardiac catheterization can be administered using a technique called coronary angioplasty. A balloon is attached to the tip of the catheter. When the balloon is in place, it is inflated and presses the plaque to the side of the blood vessel, increasing blood flow through the artery.
It was found that transradial access reduces the risk of bleeding by over 70 percent even among high-risk group. All the various applications and advantages of the transradial access procedures are believed to fuel the growth of the market.
Scope of the Report
As per the scope of the report, Transradial access is required for a catherization procedure performed for the diagnosis and treatment of arterial diseases such as peripheral artery disease and coronary artery disease, among others.
Key Market Trends
Drug Administration is Expected to be the Fastest Growing Sub-Segment in the Application
The drug administration segment of the transradial access market is believed to grow faster during the forecast period. This is majorly due to the growing usage of vascular access devices over other devices especially for the treatment of infectious diseases and some of the life-threatening diseases such as Cancer. In addition, The rising prevalence of chronic diseases across the globe is another factor augmenting the growth of this segment.
North America Dominates the Market and is Expected to Follow the Same Trend for Few More Years
The North American market is likely to grow with the highest growth rate, owing to factors such as the growing prevalence of CVDs, a rising number of conferences and workshops, the large number of cancer patients, and increase in research and clinical trials for vascular access devices. APAC is also expected to show a substantial increase in CAGR since there is a huge population suffering from cardiovascular diseases.
Competitive Landscape
The transradial access market is competitive and is inclusive of the big players along with some of the local players in the market. Some of the key players of the market include Becton, Dickinson and Company, Boston Scientific Corporation, Edward Lifesciences Corporation, Medtronic plc, and Terumo Corporation.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
4.2.2 Growing Prevalence of Cardiovascular Diseases Due to Lifestyle Related Diseases
4.2.3 Growing Use of Radial Access Devices in Pediatric Patients
4.3 Market Restraints
4.3.1 High Costs Involved in the Placement and Maintenance of Vascular Access Devices
4.3.2 Lack of Trained Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Catheters
5.1.2 Guidewires
5.1.3 Sheaths and Sheath Introducers
5.1.4 Accessories
5.2 By Application
5.2.1 Drug Administration
5.2.2 Fluid and Nutrition Administration
5.2.3 Blood Transfusion
5.2.4 Diagnostics and Testing
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics and Ambulatory Care Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ameco Medical
6.1.2 Angiodynamics, Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 Boston Scientific Corporation
6.1.5 Edward Lifesciences Corporation
6.1.6 Medtronic plc
6.1.7 Merit Medical Systems
6.1.8 Nipro Medical Corporation
6.1.9 Oscor Inc
6.1.10 Smiths Medical
6.1.11 Teleflex Incorporated
6.1.12 Terumo Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Catheters
Guidewires
Sheaths and Sheath Introducers
Accessories
By Application
Drug Administration
Fluid and Nutrition Administration
Blood Transfusion
Diagnostics and Testing
By End User
Hospitals
Clinics and Ambulatory Care Centers
Others
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America